HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial.

Abstract
A randomized, double-blind, placebo-controlled trial was conducted to evaluate the effectiveness of a sucralfate mouthwash in preventing and alleviating oral mucositis induced by 5-fluorouracil (5FU). A total of 81 patients with colorectal cancer were enrolled. Patients were studied during their first cycle of chemotherapy with 5FU and leucovorin (LV) daily for 5 days every 4 weeks (Mayo Clinic schedule). Patients were randomly allocated to receive either a sucralfate suspension or a placebo suspension that was identical in appearance. Patients were instructed to use the suspension as a mouthwash four times daily from the beginning of the chemotherapy cycle. All patients received oral cryotherapy. Patients graded the severity of their own symptoms on a daily basis, and this was the primary outcome measure. There was no difference in the frequency or severity of oral mucositis between the sucralfate- and the placebo-treated group. Some mucositis was reported by 79% of the patient group. Assessment of mucositis by trial staff underestimated the incidence of this problem. Results of this trial do not support the hypothesis that a sucralfate mouthwash can prevent or alleviate oral mucositis induced by 5FU. Patient reporting of mucositis is a more sensitive instrument for assessment of mucositis than review by medical staff.
AuthorsMichelle Nottage, Sue-Anne McLachlan, Mary-Anne Brittain, Amit Oza, David Hedley, Ronald Feld, Lillian L Siu, Gregory Pond, Malcolm J Moore
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (Support Care Cancer) Vol. 11 Issue 1 Pg. 41-7 (Jan 2003) ISSN: 0941-4355 [Print] Germany
PMID12527953 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Ulcer Agents
  • Antimetabolites, Antineoplastic
  • Mouthwashes
  • Placebos
  • Sucralfate
  • Fluorouracil
Topics
  • Administration, Oral
  • Aged
  • Anti-Ulcer Agents (administration & dosage, pharmacology)
  • Antimetabolites, Antineoplastic (adverse effects, therapeutic use)
  • Double-Blind Method
  • Female
  • Fluorouracil (adverse effects, therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Mouth Mucosa (pathology)
  • Mouthwashes
  • Placebos (administration & dosage)
  • Stomatitis (drug therapy, etiology, prevention & control)
  • Sucralfate (administration & dosage, pharmacology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: